Appropriateness of antiplatelet therapy for primary and secondary cardio‐ and cerebrovascular prevention in acutely hospitalized older people

No abstract is available for this paper.

• Publication year

  2017

• Venue

  British Journal of Clinical Pharmacology

• Publication date

  2017-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/bcp.13355PMID 28722184PMCID PMC5651307
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Appropriateness of antiplatelet therapy for primary and secondary cardio‐ and cerebrovascular prevention in acutely hospitalized older people

  2017cited by this paper
• Antiplatelet Management for Coronary Heart Disease: Advances and Challenges

  2016cited by this paper
• Aspirin for Stroke Prevention in Elderly Patients With Vascular Risk Factors: Japanese Primary Prevention Project

  2016cited by this paper
• Safety of Antithrombotic Agents in Elderly Patients with Acute Coronary Syndromes

  2016cited by this paper
• Changes in clinical outcomes for community‐dwelling older people exposed to incident chronic polypharmacy: a comparison between 2001 and 2009

  2016cited by this paper
• Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer.

  2016cited by this paper
• Defining Aging Phenotypes and Related Outcomes: Clues to Recognize Frailty in Hospitalized Older Patients

  2016cited by this paper
• 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

  2016cited by this paper
• Platelet Count and Major Bleeding in Patients Receiving Vitamin K Antagonists for Acute Venous Thromboembolism, Findings From Real World Clinical Practice

  2015cited by this paper
• Cardiovascular disease in Europe 2015: epidemiological update.

  2015cited by this paper
• Cardiovascular disease in Europe--epidemiological update 2015.

  2015cited by this paper
• Clopidogrel and Aspirin versus Aspirin Alone for Stroke Prevention: A Meta-Analysis

  2015cited by this paper
• Variations in Acute Hospital Stroke Care and Factors Influencing Adherence to Quality Indicators in 6 European Audits

  2015cited by this paper
• The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands

  2015cited by this paper
• Trends in Early Aspirin Use Among Patients With Acute Myocardial Infarction in China, 2001–2011: The China PEACE‐Retrospective AMI Study

  2014cited by this paper
• Platelet count and aging

  2014cited by this paper
• Aspirin therapy in primary cardiovascular disease prevention: a position paper of the European Society of Cardiology working group on thrombosis.

  2014cited by this paper
• Aspirin overutilization for the primary prevention of cardiovascular disease

  2014cited by this paper
• Changes in drug prescribing to Italian community-dwelling elderly people: the EPIFARM–Elderly Project 2000–2010

  2014cited by this paper
• STOPP/START criteria for potentially inappropriate prescribing in older people: version 2

  2014cited by this paper
• Secondary prevention of stroke in elderly people in Poland--results of PolSenior study.

  2014cited by this paper
• Multimorbidity and polypharmacy in the elderly: lessons from REPOSI

  2014cited by this paper
• Age and sex inequalities in the prescription of evidence-based pharmacological therapy following an acute coronary syndrome in Portugal: the EURHOBOP study

  2013cited by this paper
• Outcomes, Health Costs and Use of Antiplatelet Agents in 7,082 Patients Admitted for an Acute Coronary Syndrome Occurring in a Large Community Setting

  2013cited by this paper
• Age- And Sex-Related Variations in Platelet Count in Italy: A Proposal of Reference Ranges Based on 40987 Subjects' Data

  2013cited by this paper
• Risk factors for hospital readmission of elderly patients.

  2013cited by this paper
• American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

  2012cited by this paper
• European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012)

  2012cited by this paper
• American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

  2012cited by this paper
• Aspirin for Primary Prevention of Cardiovascular Events in the Elderly

  2012cited by this paper
• Oral anticoagulant and antiplatelet drugs used in prevention of cardiovascular events in elderly people in Poland

  2012cited by this paper
• Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

  2010cited by this paper
• Secondary Prevention

  2010cited by this paper
• Agranulocytosis and hepatic toxicity with ticlopidine therapy: a case report

  2010cited by this paper
• Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

  2010cited by this paper
• Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

  2010cited by this paper
• Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

  2009cited by this paper
• The burden of cardiovascular disease in the elderly: morbidity, mortality, and costs.

  2009cited by this paper
• European guidelines on cardiovascular disease prevention in clinical practice: executive summary.

  2007cited by this paper
• European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invit

  2007cited by this paper
• Aspirin overprescription in primary cardiovascular prevention.

  2006cited by this paper
• Guidelines on cardiovascular disease prevention in clinical practice: the European perspective

  2005cited by this paper
• Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE).

  2004cited by this paper
• Aspirin for the Prevention of Cardiovascular Events in the Elderly

  2003cited by this paper
• PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Inappropriate medication use among hospitalized older adults in Italy : results from the Italian Group of Pharmacoepidemiology in the Elderly

  2003cited by this paper
• Secondary Prevention of Stroke in Italy: A Cross-Sectional Survey in Family Practice

  2003cited by this paper
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

  2002cited by this paper
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

  2002cited by this paper
• Ticlopidine‐induced aplastic anemia: Two new case reports, review, and meta‐analysis of 55 additional cases

  2002cited by this paper
• Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis

  2000cited by this paper

• Should platelet transfusion be used to reverse preinjury antiplatelet agents in traumatic brain injury? A systematic review and meta-analysis.

  2026cites this paper
• Association of Aspirin Use in Primary Prevention and Cardiovascular Events: A Retrospective Analysis of the VITAL Cohort

  2025cites this paper
• GPs’ decision-making behaviour in the prescription of aspirin for primary prevention in elderly individuals: a qualitative study using semistructured interviews in France

  2025cites this paper
• Appropriateness of Antiplatelet Therapy and Proton Pump Inhibitor Prescribing in End-Stage Kidney Disease: A Retrospective Quality Investigation Study

  2025cites this paper
• Antiplatelet Therapy in Myocardial Bridge: Insights From the RIALTO Registry

  2025cites this paper
• Drug prescription appropriateness in hospitalized older patients: 15-year results and lessons from a countrywide register

  2024cites this paper
• Incidence and prognosis of first-ever intracerebral hemorrhage on antiplatelet therapy over 10 years in a population-based stroke registry

  2024cites this paper
• Use of Antiplatelets for Primary and Secondary Prevention of Cardiovascular Events in the Medical Outpatient Setting of a Tertiary Centre in Nigeria: A Six-Month Review

  2023cites this paper
• Aspirin in hepatocellular carcinoma: Is it an out-of-date or promising treatment?

  2022cites this paper
• The Characteristics of Patients With Possible Transient Ischemic Attack and Minor Stroke in the Hunter and Manning Valley Regions, Australia (the INSIST Study)

  2020influential citation
• Prescription Rates for Antiplatelet Therapy (APT) in Coronary Artery Disease (CAD) – What Benchmark are We Aiming at in Continuing Medical Education (CME)?

  2020cites this paper
• Use and prescription appropriateness of drugs for peptic ulcer and gastrooesophageal reflux disease in hospitalized older people

  2019cites this paper
• Spotlight Commentary: What's new with the old drug aspirin in older adults?

  2019cites this paper
• Spotlight—Introducing a new Commentary series for the BJCP

  2019cites this paper
• Antibiotic use and associated factors in a large sample of hospitalized older people.

  2019cites this paper
• Simulation-based education for physicians to increase oral anticoagulants in hospitalized elderly patients with atrial fibrillation.

  2019cites this paper
• Inappropriate prescription of benzodiazepines in acutely hospitalized older patients.

  2019cites this paper
• Appropriateness of prescription of oral anticoagulant therapy in acutely hospitalized older people with atrial fibrillation. Secondary analysis of the SIM‐AF cluster randomized clinical trial

  2019cites this paper
• Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients.

  2019cites this paper
• Aspirin in primary prevention: the triumph of clinical judgement over complex equations

  2019cites this paper
• Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation

  2018cites this paper
• Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register

  2018cites this paper
• Preventable ADRs leading to hospitalization — results of a long-term prospective safety study with 6,427 ADR cases focusing on elderly patients

  2018cites this paper
• Appropriateness of antiplatelet therapy for primary and secondary cardio‐ and cerebrovascular prevention in acutely hospitalized older people

  2017cites this paper